That question is one of several the Phase 3 obesity studies were designed to answer, and, as discussed below, the first of those readouts has now arrived
What is the recommended protocol for using GHK-Cu (Glycyl-Histidyl-Lysine-Copper) peptide in clinical practice for wound healing and tissue repair?
All housing, handling, and experimentation that involved the rats were conducted following the procedures set in place by the National Institutes of Health guide for the care and usage of laboratory animals [2]
To do this, your doctor or pharmacist will typically give you a short 30-gauge needle
The rest of it contains urea, electrolytes, and other compounds
Safety and efficacy in humans remain unestablished